ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.150
+0.650 (43.33%)
At close: Aug 28, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 65.34 million as of August 28, 2026. Its market cap has decreased by -41.89% in one year.
Market Cap
65.34M
Enterprise Value
64.83M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.15
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 65.34M, an increase of 352.74%. That is a compound annual growth rate of 68.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 65.34M | -45.64% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 52.05M |
| MedMira | 49.12M |
| BriaCell Therapeutics | 45.15M |
| Medicenna Therapeutics | 43.84M |
| Microbix Biosystems | 43.83M |
| Sernova Biotherapeutics | 41.54M |
| Sona Nanotech | 41.14M |
| Defence Therapeutics | 39.41M |